58
Views
0
CrossRef citations to date
0
Altmetric
Articles

Impact of Radiation Therapy on Biological Parameters in Cancer Patients: Sub-analysis from the RIT Prospective Epidemiological Study

, ORCID Icon, ORCID Icon, , , , , , & show all
Pages 109-118 | Received 04 Oct 2021, Accepted 20 Oct 2022, Published online: 09 Nov 2022

References

  • Sia J, Szmyd R, Hau E, Gee HE. Molecular mechanisms of radiation-induced cancer cell death: a primer. Front Cell Dev Biol. 2020;8:41. doi:10.3389/fcell.2020.00041.
  • de Andrade Carvalho H, Villar RC. Radiotherapy and immune response: the systemic effects of a local treatment. Clinics (Sao Paulo)). 2018;73(Suppl 1):e557s. doi:10.6061/clinics/2018/e557s.
  • Grassberger C, Ellsworth SG, Wilks MQ, Keane FK, Loeffler JS. Assessing the interactions between radiotherapy and antitumour immunity. Nat Rev Clin Oncol. 2019; Dec16(12):729–745. doi:10.1038/s41571-019-0238-9.
  • Abdelhalim MA-K, Al-Ayed MS, Moussa S-M, Abd Al-Sheri A-H. The effects of gamma-radiation on red blood cell corpuscles and dimensional properties in rats. Pak J Pharm Sci. 2015;28(5 Suppl):1819–1822.
  • Bai L, Zhou B-S, Zhao Y-X. Dynamic changes in T-cell subsets and C-reactive protein after radiation therapy in lung cancer patients and correlation with symptomatic radiation pneumonitis treated with steroid therapy. Cancer Manag Res. 2019;11:7925–7931. doi:10.2147/CMAR.S209286.
  • Begtrup KM, Hojbjerg JA, Offersen BV, Hvas A-M. Adjuvant radiotherapy does not affect hemostasis. Platelets. 2019;30(3):387–395. doi:10.1080/09537104.2018.1448378.
  • Paul S, Amundson SA. Gene expression signatures of radiation exposure in peripheral white blood cells of smokers and non-smokers. Int J Radiat Biol. 2011; 87(8):791–801. doi: 10.3109/09553002.2011.568574
  • Stepanović A, Nikitović M, Bogdanović A, Grujičić D. Long-lasting thrombocytopenia after transient pancytopenia induced by short-term concomitant radiotherapy and temozolomide. Eur J Case Rep Intern Med. 2020;7(10):001785. doi:10.12890/2020_001785.
  • Zachariah B, Jacob SS, Gwede C, Cantor A, Patil J, Casey L, et al. Effect of fractionated regional external beam radiotherapy on peripheral blood cell count. Int J Radiat Oncol Biol Phys. 2001;50(2):465–472. doi:10.1016/S0360-3016(00)01587-X.
  • Sanzari JK, Wan XS, Krigsfeld GS, Wroe AJ, Gridley DS, Kennedy AR. The effects of gamma and proton radiation exposure on hematopoietic cell counts in the ferret model. Gravit Space Res. 2013;1(1):79–94. doi:10.2478/gsr-2013-0007.
  • El-Shanshoury H, El-Shanshoury G, Abaza A. Evaluation of low dose ionizing radiation effect on some blood components in animal model. J Radiat Res Appl Sci. 2016;9(3):282–293. doi:10.1016/j.jrras.2016.01.001.
  • Chargari C, Magne N, Guy J-B, Rancoule C, Levy A, Goodman KA, et al. Optimize and refine therapeutic index in radiation therapy: overview of a century. Cancer Treat Rev. 2016;45:58–67. doi:10.1016/j.ctrv.2016.03.001.
  • Blank KR, Cascardi MA, Kao GD. The utility of serial complete blood count monitoring in patients receiving radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 1999;44(2):317–321. doi:10.1016/S0360-3016(99)00018-8.
  • Cozzarini C, Noris Chiorda B, Sini C, Fiorino C, Briganti A, Montorsi F, et al. Hematologic toxicity in patients treated with postprostatectomy whole-pelvis irradiation with different intensity modulated radiation therapy techniques is not negligible and is prolonged: preliminary results of a longitudinal, observational study. Int J Radiat Oncol Biol Phys. 2016;95(2):690–695. doi:10.1016/j.ijrobp.2016.01.022.
  • Pinkawa M, Djukic V, Klotz J, Petz D, Piroth MD, Holy R, et al. Hematologic changes during prostate cancer radiation therapy are dependent on the treatment volume. Future Oncol. 2014;10(5):835–843. doi:10.2217/fon.13.237.
  • Sini C, Fiorino C, Perna L, Noris Chiorda B, Deantoni CL, Bianchi M, et al. Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation. Radiother Oncol. 2016;118(1):79–84. doi:10.1016/j.radonc.2015.11.020.
  • Yang FE, Vaida F, Ignacio L, Houghton A, Nauityal J, Halpern H, et al. Analysis of weekly complete blood counts in patients receiving standard fractionated partial body radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33(3):617–617.
  • Kiprian D, Czarkowska-Paczek B, Wyczalkowska-Tomasik A, Fuksiewicz M, Kotowicz B, Paczek L. Radiotherapy and radiochemotherapy increase serum levels of pro-inflammatory interleukin-6 and C-reactive protein in patients with head and neck cancers. Transl Cancer Res. 2018;7(1):41–47. doi:10.21037/tcr.2017.12.23.
  • Andersson B-Å, Lewin F, Lundgren J, Nilsson M, Rutqvist L-E, Löfgren S, et al. Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol. 2014;140(3):515–519. doi:10.1007/s00432-014-1592-8.
  • Louneva N, Maity A, Kennedy AR. Plasma D-dimer levels are elevated in radiation oncology patients. Radiat Res. 2020;193(1):46–53. doi:10.1667/RR15429.1.
  • Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia. Cancer. 2004;100(2):228–237. doi:10.1002/cncr.11882.
  • Fontanella C, Bolzonello S, Lederer B, Aprile G. Management of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropenia. Breast Care. 2014;9(4):239–245. doi:10.1159/000366466.
  • Franco RS. Measurement of red cell lifespan and aging. Transfus Med Hemother. 2012;39(5):302–307. doi:10.1159/000342232.
  • Bastianutto C, Mian A, Symes J, Mocanu J, Alajez N, Sleep G, et al. Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow. Cancer Res. 2007;67(21):10112–10116. doi:10.1158/0008-5472.CAN-07-2192.
  • Tang JT, Yamazaki H, Nishimoto N, Inoue T, Nose T, Koizumi M, et al. Effect of radiotherapy on serum level of interleukin 6 in patients with cervical carcinoma. Anticancer Res. 1996;16(4A):2005–2008.
  • Wu Y, Potempa LA, El Kebir D, Filep JG. C-reactive protein and inflammation: conformational changes affect function. Biol Chem. 2015;396(11):1181–1197. doi:10.1515/hsz-2015-0149.
  • da Silva IA, de Sousa Andrade LN, Jancar S, Chammas R. Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy. Clinics. 2018;73(suppl 1):e792s. http://www.scielo.br/j/clin/a/YfGkMCKP4Kp4mnc7znS6nMf/abstract/?lang=en doi:10.6061/clinics/2018/e792s.
  • Nimker S, Sharma K, Saraswathy R, Chandna S. Delineating the effects of ionizing radiation on erythropoietic lineage-implications for radiation biodosimetry. Health Phys. 2019;116(5):677–693. doi:10.1097/HP.0000000000000975.
  • Kumar T, Schernberg A, Busato F, Laurans M, Fumagalli I, Dumas I, et al. Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation. Cancer Manag Res. 2019;11:6285–6297. doi:10.2147/CMAR.S195989.
  • Yuan C, Wang Q. Comparative analysis of the effect of different radiotherapy regimes on lymphocyte and its subpopulations in breast cancer patients. Clin Transl Oncol. 2018; 20(9):1219–1225. doi:10.1007/s12094-018-1851-2.
  • Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, et al. The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. Cancer. 2013;119(18):3272–3279. doi:10.1002/cncr.28185.
  • Halaby R, Popma CJ, Cohen A, Chi G, Zacarkim MR, Romero G, et al. D-Dimer elevation and adverse outcomes. J Thromb Thrombolysis. 2015;39(1):55–59. doi:10.1007/s11239-014-1101-6.
  • Linkins L-A, Takach Lapner S. Review of D-dimer testing: good, bad, and ugly. Int J Lab Hematol. 2017;39(Suppl 1):98–103. doi:10.1111/ijlh.12665.
  • Liu P, Zhu Y, Liu L. Elevated pretreatment plasma D-dimer levels and platelet counts predict poor prognosis in pancreatic adenocarcinoma. Onco Targets Ther. 2015;8:1335–1340. doi:10.2147/OTT.S82329.
  • Yang X, Ren H, Sun Y, Zhang L, Yang X, Li H, et al. The prognostic value of D-dimer levels in endometrial cancer patients treated with intensity-modulated radiation therapy. Oncotarget. 2017;8(15):25279–25288. doi:10.18632/oncotarget.15805.
  • Ay C, Dunkler D, Pirker R, Thaler J, Quehenberger P, Wagner O, et al. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica. 2012;97(8):1158–1164. doi:10.3324/haematol.2011.054718.
  • Snow H, Mitchell C, Hendry S, McKinley M, Byrne D, Ngan S, et al. Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapy. J Surg Oncol. 2021;123(1):117–126. doi:10.1002/jso.26261.
  • Pouliliou SE, Lialiaris TS, Dimitriou T, Giatromanolaki A, Papazoglou D, Pappa A, et al. Survival fraction at 2 Gy and γH2AX expression kinetics in peripheral blood lymphocytes from cancer patients: relationship with acute radiation-induced toxicities. Int J Radiat Oncol Biol Phys. 2015;92(3):667–674. doi:10.1016/j.ijrobp.2015.02.023.
  • Dai D, Tian Q, Shui Y, Li J, Wei Q. The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: a systematic review and meta-analysis. Radiother Oncol. 2022;168:28–36. doi:10.1016/j.radonc.2022.01.003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.